Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes - Concepedia

Concepedia

Publication | Closed Access

Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

599

Citations

30

References

2001

Year

Shayan Sharif, Guillermo Arreaza, Peter Zucker, Qing‐Sheng Mi, Jitin Sondhi, Olga V. Naidenko, Mitchell Kronenberg, Yasuhiko Koezuka, Terry L. Delovitch, Jean‐Marc Gombert,

Nature Medicine

Autoimmune Type 1Autoimmune DiseaseAllergyAdaptive Immune SystemDiabetesImmunologyImmune RegulationIslet Cell ManufacturingSelf-toleranceT Cell ImmunityAutoimmunityImmunomodulationImmunosuppressionImmunotherapyMedicineα-Galactosylceramide TreatmentRegulatory T Cell Biology

References

	Year	Citations

Page 1

Page 1